Literature DB >> 10545177

Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin.

M W Pennington1, M D Lanigan, K Kalman, V M Mahnir, H Rauer, C T McVaugh, D Behm, D Donaldson, K G Chandy, W R Kem, R S Norton.   

Abstract

ShK toxin, a potassium channel blocker from the sea anemone Stichodactyla helianthus, is a 35 residue polypeptide cross-linked by three disulfide bridges: Cys3-Cys35, Cys12-Cys28, and Cys17-Cys32. To investigate the role of these disulfides in the structure and channel-blocking activity of ShK toxin, a series of analogues was synthesized by selective replacement of each pair of half-cystines with two alpha-amino-butyrate (Abu) residues. The remaining two disulfide pairs were formed unambiguously using an orthogonal protecting group strategy of Cys(Trt) or Cys(Acm) at the appropriate position. The peptides were tested in vitro for their ability to block Kv1.1 and Kv1.3 potassium channels and their ability to displace [(125)I]dendrotoxin binding to rat brain synaptosomal membranes. The monocyclic peptides showed no activity in these assays. Of the dicyclic peptides, [Abu12,28]ShK(3-35,17)(-)(32) (where the subscript indicates disulfide connectivities) had weak activity on Kv1.3 and Kv1.1. [Abu17,32]ShK(3-35,12)(-)(28) blocked Kv1.3 with low nanomolar potency, but was less effective (being comparable to [Abu12,28]ShK(3-35,17)(-)(32)) against Kv1.1. [Abu3, 35]ShK(12-28,17)(-)(32), retained high picomolar affinity against both channels. Corroborating these results, [Abu3,35]ShK(12-28, 17)(-)(32) had an IC(50) ratio relative to native toxin of 18 in the displacement assay, whereas [Abu17,32]ShK(3-35,12)(-)(28) and [Abu12, 28]ShK(3-35,17)(-)(32) had ratios of 69 and 390, respectively. Thus, the disulfide bond linking the N- and C-terminal regions is less important for activity than the internal disulfides. NMR analysis of the [Abu12,28] and [Abu17,32] analogues indicated that they had little residual structure, consistent with their significantly reduced activities. By contrast, [Abu3,35]ShK(12-28,17)(-)(32) had a moderately well-defined solution structure, with a mean pairwise root-mean-square deviation of 1.33 A over the backbone heavy atoms. This structure nevertheless showed significant differences from that of native ShK toxin. The possible interactions of this analogue with the channel and the distinction between native secondary and tertiary structure on one hand and global topology imposed by the disulfide bridges on the other are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10545177     DOI: 10.1021/bi991282m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes.

Authors:  M W Pennington; C Beeton; C A Galea; B J Smith; V Chi; K P Monaghan; A Garcia; S Rangaraju; A Giuffrida; D Plank; G Crossley; D Nugent; I Khaytin; Y Lefievre; I Peshenko; C Dixon; S Chauhan; A Orzel; T Inoue; X Hu; R V Moore; R S Norton; K G Chandy
Journal:  Mol Pharmacol       Date:  2009-01-02       Impact factor: 4.436

Review 2.  Early engineering approaches to improve peptide developability and manufacturability.

Authors:  Jennifer L Furman; Mark Chiu; Michael J Hunter
Journal:  AAPS J       Date:  2014-10-23       Impact factor: 4.009

Review 3.  Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.

Authors:  Victor Chi; Michael W Pennington; Raymond S Norton; Eric J Tarcha; Luz M Londono; Brian Sims-Fahey; Sanjeev K Upadhyay; Jonathan T Lakey; Shawn Iadonato; Heike Wulff; Christine Beeton; K George Chandy
Journal:  Toxicon       Date:  2011-08-12       Impact factor: 3.033

4.  Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria.

Authors:  Shih Chieh Chang; Charles A Galea; Eleanor W W Leung; Rajeev B Tajhya; Christine Beeton; Michael W Pennington; Raymond S Norton
Journal:  Toxicon       Date:  2012-05-31       Impact factor: 3.033

5.  Structure of the analgesic mu-conotoxin KIIIA and effects on the structure and function of disulfide deletion.

Authors:  Keith K Khoo; Zhi-Ping Feng; Brian J Smith; Min-Min Zhang; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj; Raymond S Norton
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

6.  Structurally minimized mu-conotoxin analogues as sodium channel blockers: implications for designing conopeptide-based therapeutics.

Authors:  Tiffany S Han; Min-Min Zhang; Aleksandra Walewska; Pawel Gruszczynski; Charles R Robertson; Thomas E Cheatham; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj
Journal:  ChemMedChem       Date:  2009-03       Impact factor: 3.466

7.  Cyclic analogues of α-conotoxin Vc1.1 inhibit colonic nociceptors and provide analgesia in a mouse model of chronic abdominal pain.

Authors:  Joel Castro; Luke Grundy; Annemie Deiteren; Andrea M Harrington; Tracey O'Donnell; Jessica Maddern; Jessi Moore; Sonia Garcia-Caraballo; Grigori Y Rychkov; Rilei Yu; Quentin Kaas; David J Craik; David J Adams; Stuart M Brierley
Journal:  Br J Pharmacol       Date:  2018-02-13       Impact factor: 8.739

8.  Less is More: Design of a Highly Stable Disulfide-Deleted Mutant of Analgesic Cyclic α-Conotoxin Vc1.1.

Authors:  Rilei Yu; Victoria A L Seymour; Géza Berecki; Xinying Jia; Muharrem Akcan; David J Adams; Quentin Kaas; David J Craik
Journal:  Sci Rep       Date:  2015-08-20       Impact factor: 4.379

9.  Functional transcriptomic analysis of the role of MAB-5/Hox in Q neuroblast migration in Caenorhabditis elegans.

Authors:  Joel V Tamayo; Mahekta Gujar; Stuart J Macdonald; Erik A Lundquist
Journal:  BMC Genomics       Date:  2013-05-04       Impact factor: 3.969

10.  A Polychaete's powerful punch: venom gland transcriptomics of Glycera reveals a complex cocktail of toxin homologs.

Authors:  Björn M von Reumont; Lahcen I Campbell; Sandy Richter; Lars Hering; Dan Sykes; Jörg Hetmank; Ronald A Jenner; Christoph Bleidorn
Journal:  Genome Biol Evol       Date:  2014-09-05       Impact factor: 3.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.